World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00885573
Date of registration: 21/04/2009
Prospective Registration: No
Primary sponsor: University Hospital, Grenoble
Public title: Pharyngeal Sensitivity in Diagnosis Algorithm for Sleep Apnea Syndrome SENSITEST
Scientific title: Measurement of Pharyngeal Sensitivity With the SENSITEST Device: Validation of the Diagnosis Algorithm for Sleep Disordered Breathing
Date of first enrolment: December 2008
Target sample size: 52
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00885573
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
France Switzerland
Contacts
Name:     Maurice DEMATTEIS, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Grenoble
Key inclusion & exclusion criteria

Inclusion Criteria:

- consecutively included patients with suspicion of sleep apnea syndrome

- patients who have signed the informed consent form

- patients with body mass index less than or equal 30 kg/m2

Exclusion Criteria:

- body mass index more than 30 kg/m2

- pharyngeal infection or allergic rhinitis less than 2 weeks before recordings

- craniofacial anomalies and/or limited mouth opening and/or teeth position
compromising mouthpiece installation and stability during measurement

- instable dentures

- exaggerated gag reflex preventing pharynx examination

- no visibility of the soft palate

- systemic or topical anti-inflammatory treatments

- treatments that may increase the occurence of nocturnal respiratory events and/or
leading to daytime sleepiness and cognitive impairment

- cardiac failure, or symptoms suggesting cardiac failure

- history of stroke

- contraindication for using xylocaine spray

- no affiliation to national insurance

- patient participating in another research study involving drugs that may interfere
with sleep recordings and/or measurement of pharyngeal sensation

- patient subjected to exclusion period following participation in another research
study



Age minimum: 30 Years
Age maximum: 65 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Sleep Apnea Syndrome
Intervention(s)
Device: Measurement of pharyngeal sensitivity (SENSITEST)
Primary Outcome(s)
We aim to compare the novel diagnosis method with nocturnal polysomnography which is the reference method to diagnose sleep disordered breathing. [Time Frame: Measurement performed the morning following the nocturnal polysomnography]
Secondary Outcome(s)
We will determine the severity of sleep apnea for which pharyngeal sensitivity is predictive of sleep apnea syndrome. To simplify the procedure, we will precise the role of pharyngeal anesthesia in the diagnostic predictive value of the algorithm. [Time Frame: similar to primary outcome measure]
Secondary ID(s)
2008-A00451-54
0808
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University Hospital of Liege
Poitiers University Hospital
University Hospital, Geneva
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history